baber/WOPTO huggingface dataset:
Patent NZ-505463-A (NZ)
Title: Forgery prevention sheet
Inventor: HANEDA AKIRA
IPC: B32B7/023
Filed: 1999-10-07
Abstract: A multi-layered sheet giving a forgery prevention effect by developing different appearances when the upper surface or lower surface is irradiated with an ultraviolet ray. In a first embodiment, fluorescence colouring layers respectively developing different hues are provided on the upper surface side and the lower surface side respectively, a fluorescence colouring layer on the upper surface side only develops a fluorescence colour to permit observation from the upper surface when an ultraviolet ray is applied from the upper surface side, and at least a fluorescence colouring layer on the lower surface side develops a colour to permit observation from the upper surface when an ultraviolet ray is applied from the lower surface side. In a second embodiment an opacity in an area extending from the upper surface to a fluorescence colouring layer is not lower than 97% and that in an area extending from the lower surface to a fluorescence colouring layer is not higher than 96%, and an ultraviolet radiation from the upper surface does not permit a printed pattern to be observed, whereas an ultraviolet radiation from the lower surface permits the printed pattern to be observed.
Patent NZ-507616-A (NZ)
Title: Preparation and xenotransplantation of porcine islets in the presence of sertoli cells, for treatment of diabetes
Inventor: ELLIOT ROBERT BARTLET
IPC: C12N5/06
Filed: 2000-10-17
Abstract: A method of preparing a xenotransplantable porcine islet preparation capable of producing porcine insulin in an appropriate mammal recipient upon xenotransplantation.  The method includes: (i) harvesting the pancreas of piglets at or near full term gestation, and (ii) extracting islets from a culture of the harvested pancreas using a suitable collagenase.  The culture of the harvested pancreas being; a. of mechanically reduced harvested pancreas, and b. a supportive mammalian albumin substantially free of non-human microbiological agents, which the islets are physically associated with Sertoli cells.  Also a method of preparing an implantable device containing as described porcine insulin for xenotransplantation in mammals.  In addition a xenotransplantable capsule, composed of biocompatible materials, allowing entry of glucose to and egress of porcine insulin from islet cells.
Patent NZ-507652-A (NZ)
Title: Stowable table for vehicle, typically aircraft, moved from stowed recessed position to deployed position by pivoting and sliding in bulk head groove
Inventor: HAITH PHILIP
IPC: B60N2/90
Filed: 1998-02-18
Abstract: Table 122 is normally in a lowered and stowed position in a bulkhead recess 120 (Fig 9c). It is pivoted about hinge 124 so as to be aligned with a horizontal groove. It can be then moved longitudinally.
Patent NZ-510421-A (NZ)
Title: Infant mattress
Inventor: SMITH SHIRLEY YVONNE
IPC: A47C27/14
Filed: 2001-03-08
Abstract: An infant mattress adapted to prevent and/or reduce the development of occipital plagiocephaly in an infant, wherein the mattress includes a depression in a head zone of the mattress which is substantially the shape and/or size of the back of an infant's skull and which is adapted to support the back of an infant's skull, a body zone adopted to support the body of the infant in substantially the supine position, and a securing member adopted to restrain and maintain the infant in the supine position on the mattress.
Patent NZ-523205-A (NZ)
Title: Preparing a sample to be analysed from a sample with very large volume
Inventor: GUILLOT EMMANUELLE
IPC: B01D61/14
Filed: 2001-06-08
Abstract: The invention concerns the use of filtering means comprising a housing (2) wherein are arranged parallel to one another a plurality of hollow fibres (3), whereof the porous wall (3a) of each defines an aperture (4), so that said means comprises a inner path and an outer path (B) corresponding to the volume available between the fibres and the disc separator for treating an initial sample with large volume comprising in diluted state a plurality of micro-organisms of different sizes. The invention is characterised in that during at least a concentration step, one single means of filtering is available, the atomic mass unit threshold of the porous wall (3a) of the fibres is determined so as to retain the smallest micro-organism of the initial sample, said means being used in frontal mode and discontinuously, thereby providing the output sample liquid, that is the concentrate.
Patent NZ-534498-A (NZ)
Title: Automatic bladder relief system
Inventor: HARVIE MARK R
IPC: A61F5/455
Filed: 2003-02-25
Abstract: An automatic or semi-automatic bladder relief system specifically designed to increase the overall sanitation and comfort for users that may require a means to dispose of their urine in the absence of other sanitary facilities due to situations such as aircraft pilots and incontinent individuals.
Patent NZ-545781-A (NZ)
Title: PDT for tattoo removal
Inventor: KJELLBOTN CHARLES RICHARD
IPC: A61N5/06
Filed: 2004-08-20
Abstract: Disclosed is the use of a benzoporphyrin derivative (BPD) or green porphyrin photosensitizer, or a species selected from tetrahydrochlorins, purpurins, porphycenes, phenothiaziniums, bacteriochlorophylls, and combinations thereof in the manufacture of a composition for treating a tattoo in tattooed tissue, the treatment comprising: (i) intradermally injecting said composition through the stratum corneum into tattooed target tissue; and (ii) irradiating the target tissue with energy at a wavelength appropriate to activate the photosensitizer, wherein the tattoo in tattooed target tissue fades or disappears.
Patent NZ-548193-A (NZ)
Title: Adjustable length breathing circuit
Inventor: BURROW KEVIN D
IPC: A61M16/08
Filed: 2005-01-07
Abstract: A unilimb breathing circuit is disclosed. The unilimb breathing circuit comprises a corrugated expiratory and inspiratory tube, a proximal end coupling member, and a distal end coupling member. The expiratory and inspiratory tubes have first and second ends, and are expandable between a fully compressed rest position and a fully expanded rest position. The tubes have a plurality of intermediate rest positions and are capable of maintaining their rest length without the exertion of an external force. In the assembled breathing circuit, the first end of the expiratory and inspiratory tubes are coupled to the proximal end coupling member, and the second end of the expiratory and inspiratory tubes are coupled to the distal end coupling member. The assembled breathing circuit is configured such that when the expiratory tube is in the fully expanded rest position, the inspiratory tube is in an intermediate rest position.
Patent NZ-548487-A (NZ)
Title: Access cover
Inventor: HILL DAVID EDWARD
Filed: 2006-07-12
Abstract: A load bearing access cover, assembly or components thereof, to close an opening, for example in a ground utility chamber or similar. The access cover has a unitary cast structural support that defines an upper side and lower side. The structural support has a lattice of structural webs defining a plurality of interstices; at least some interstices are open to both said upper and lower sides. The structural support also has a frame portion at least in part surrounding a periphery of the lattice. The frame portion connects between at least some of the structural webs. A top plate is engaged, or engageable, to the structural support from above. The top plate is at least coextensive with the structural support. The structural support and the top plate are engaged or engageable to form a unitary load bearing structure.
Patent NZ-549872-A (NZ)
Title: Anti-P-selectin antibodies
Inventor: GRAUS YVO
IPC: C07K16/46
Filed: 2005-04-05
Abstract: Disclosed is an antibody binding to P-selectin, not binding to complement factor Clq and not to Fcg receptors, that contains an Fc part derived from human origin and being characterized in that it is an antibody of human subclass IgG4 wherein S228 is replaced by P and L235 is replaced by E, and by inhibiting the adhesion of leukocyte-like HL60 cells to purified P-selectin with an IC50 value of 0.08 to 0.5 Ág/ml. Further disclosed is the use of said antibody for the preparation of a medicament for the prophylaxis or treatment of inflammatory and thrombotic disorders, including critical limb ischemia and peripheral arterial occlusive disease.
Patent NZ-556675-A (NZ)
Title: A latch
Inventor: KEIGHLEY GARTH COLIN
Filed: 2007-07-24
Abstract: A latch which is suitable for latching a window in a closed and sealed position is disclosed. The latch has latch furniture (10) adapted to fit into a window sash section (S) with minimal protrusion from the section. The furniture includes a sealing lever handle (17) and a latch release button/handle (16) located in a recess (15) in the latch furniture. The latch further includes a latch mechanism (11) adapted to engage with the latch furniture (10). The latch mechanism (11) has one or more latch bolts (65) operable by the latch release handle (16) and a latch carriage pin (41) engageable with a striker assembly which is mounted to a section of a window frame. The carriage pin (41) is coupled to the sealing lever handle (17) whereby operation of the sealing lever handle (17) moves the window section (S) into a sealing position relative to the striker assembly (12) which is mounted on a window stile/transom (T).
Patent NZ-561024-A (NZ)
Title: Inflatable containers
Inventor: FRAYNE SHAWN
IPC: B65D81/05
Filed: 2006-03-10
Abstract: An inflatable container 12, comprising a) a flexible housing 18 having an interior cavity, the housing 18 adapted to undergo at least one change in shape, and b) a flexible valve in operative association with the housing 18, the valve adapted to undergo at least one change in shape to provide fluid communication between (1) the interior cavity, and (2) the ambient environment in which the container 12 is located, wherein, when a first force is exerted on the housing 18 and a second force is exerted on the valve, the housing 18 and the valve each undergo a change in shape to draw fluid from the ambient environment, through the valve, and into the interior cavity.
Patent NZ-570386-A (NZ)
Title: Extension cushions for side wings of child vehicle safety seat
Inventor: LUMLEY MIKE
Filed: 2008-08-07
Abstract: To improve the side impact protection offered by a child's automotive safety seat, side wing extensions 16 are secured to the respective side wings 14 of the backrest of the seat. The extensions are resilient and extend forwardly of the side wings 14 of the backrest 12.
Patent NZ-573130-A (NZ)
Title: Improvements in liquid heating vessels
Inventor: MOUGHTON COLIN PETER
IPC: A47J27/21
Filed: 2008-11-26
Abstract: A liquid heating vessel comprises a heater forming at least part of the base of the vessel, the heater comprising a heater plate and an electric heating element attached to or formed on the underside of the heater plate. The vessel further comprises a disrupter member 118 having an annular part 120 disposed above and extending over at least part of the upper surface of the heater plate opposite where the heating element is provided. The surface of the annular part 120 in contact with liquid below the disrupter member 118 is generally concave. The disrupter member 118 is arranged in use to partially isolate a layer of liquid directly above the heating element. This can reduce the noise produced by the vessel in heating or boiling water.
Patent NZ-574240-A (NZ)
Title: Improved water treatment method
Inventor: ANDERSON STUART BRUCE
IPC: C02F1/461
Filed: 2007-06-27
Abstract: Disclosed is a method for treatment of a body of water of pH at least about 7, to eliminate or reduce the effects of micro-organisms for the sanitization of water in a swimming pool or the like, wherein the method comprises the steps of forming, in a body of water, an electrolyte solution containing from 1500 ppm to 9000 ppm of a soluble magnesium halide salt and 500 ppm to 3000 ppm of a soluble potassium salt; treating said electrolyte solution in an electrolytic halogenation cell to form an aqueous solution of hypohalous acid; and, returning treated electrolyte solution to said body of water (swimming pool). A mixture of magnesium chloride and potassium chloride with small quantities of soluble alkaline earth metal bromide (such as sodium, potassium, calcium, magnesium or lithium bromide) is particularly effective in the sanitization process.
Patent NZ-578815-A (NZ)
Title: A traffic signal control system and method
Inventor: BRANAGAN JOHN
IPC: G08G1/07
Filed: 2009-07-31
Abstract: A traffic signal control system is disclosed. The system includes a traffic signal control module (110) powered by an external alternating current source (160) and an auxiliary power module (120) having an internal direct current source (122) and coupled to the traffic signal control module to selectively power the traffic signal control module. The auxiliary power module is configured to be selectively connected to an external direct current source (151) via an electrical lead (126). The traffic signal control module is configured to be powered by the auxiliary power module and selectively by the external direct current source when the external alternating current source is interrupted.
Patent NZ-586792-A (NZ)
Title: Tamper resistant controlled release pharmaceutical tablets form having convex and concave surfaces
Inventor: JANS EUGEEN MARIE JOZEF
IPC: A61K9/20
Filed: 2009-01-23
Abstract: Disclosed is a thermoformed pharmaceutical dosage form (such as in tablet form) with controlled release of a pharmacologically psychotropically active compound (A) (such as tapentadol) contained therein, the pharmaceutical dosage form having a breaking strength B1 of at least 500 N in direction of extension E1 and having a breaking strength B2 of less than 500 N in direction of extension E2; wherein a portion of the surface of the pharmaceutical dosage form is convex, another portion of its surface is concave; the content of the pharmacologically active compound (A) is at least 0.5 wt % based on the total weight of the dosage form; the dosage form contains polymer (C), which is a polyalkylene oxide (and preferably a polyethylene oxide) having a weight average molecular weight of at least 200,000 g/mol; the content of polymer (C) is at least 15 wt. %, based on the total weight of the dosage form; the pharmacologically active compound (A) is embedded in the polymer (C); and the pharmaceutical dosage form is adapted for oral administration once daily or twice daily.
Patent NZ-590716-A (NZ)
Title: Led module
Inventor: MAGLICA ANTHONY
IPC: H01L33/00
Filed: 2009-08-07
Abstract: 590716 A lighting module 100, comprising a circuit board 30, a light emitting diode 20 attached to the circuit board 30, and a heat sink 101 attached to the circuit board 30. The heat sink 101 includes an outer housing 100 and a ring 40 that is at least partially located within the outer housing 101.
Patent NZ-593088-A (NZ)
Title: 8-([Hetero]aryl)-6-(4-alkyl-piperazin-1-yl)-9H-purine derivatives and uses thereof in the treatment of pain
Inventor: ASTLES PETER CHARLES
IPC: C07D473/34
Filed: 2009-12-09
Abstract: Disclosed are 8-([Hetero]aryl)-6-(4-alkyl-piperazin-1-yl)-9H-purine derivatives as represented by the general formula (I), wherein R1 is selected from H, F, Cl, alkyl, CF3, cyclopropyl, OCH3, OCF3 and CN; R2 is selected from tetrahydrofuranyl, tetrahydropyranyl, azetidine-1-carboxylic acid methyl ester and tetrahydrothiophene-1,1-dioxide; R3 is H or combines with R4 to form a fused pyrrolidin-2-one; R4 is selected from alkyl, fluoroalkyl, cyclopropyl and COCH3; R5 is selected from H, CH3 and CF3; n is 0 or 1; X1 and X3 are independently selected from N, CH and CR6; X2 is selected from CH and CR6; with the proviso that only one of X1, X2 and X3 may be other than CH; R6 is selected from F, Cl, CF3, OCH3 and OCF3; or a pharmaceutically acceptable salt thereof. Representative compounds include 8-(2-chloro-pyridin-3-yl)-2-methyl-6-(4-methyl-piperazin-1-yl)-9-(R)-tetrahydro-furan-3-yl-9H-purine, 2-methyl-6-(4-methyl-piperazin-1-yl)-9-(tetrahydro-pyran-4-yl)-8-(2-trifluoromethylphenyl)-9H-purine and 8-(2-chloro-phenyl)-2-methyl-6-(4-methyl-piperazin-1-yl)-9-(tetrahydro-pyran-4-yl)-9H-purine. Also disclosed is a pharmaceutical composition which comprises a compound as defined above, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable diluent or carrier, for the treatment of pain and osteoarthritic pain.
Patent NZ-596912-A (NZ)
Title: A grass covering system using a mat with at least one aperture and a vehicle to dispense the mat
Inventor: WALDON JOHN CHARLES
IPC: A01G13/02
Filed: 2011-12-06
Abstract: Disclosed is a system for laying a ground protection mat (7). The system includes at least one ground protection mat, each mat having at least one aperture (8). A vehicle or trailer (2) is used for transporting and dispensing the at least one ground protection mat, the vehicle or trailer including a spindle (4); and a linking device configure to link the mat to the spindle via the aperture. A geared winch (6) may be attached to the spindle to assist in rotation of the spindle.
Patent NZ-600463-A (NZ)
Title: Body surfing suit with fins
Inventor: GADLER NICHOLAS NOEL
IPC: A41D7/00
Filed: 2010-12-14
Abstract: 600463 A body surfing apparatus comprising a body suit having a torso 160 and legs 106, a plurality of fins 120c located on the torso, and one or more fins 120c, 120d located laterally on the legs. The fins are attached to the body suit via an adhesive or mechanical means. The fins and suit are covered with a buoyant layer which has a minimum thickness of 1 mm.
Patent NZ-610238-A (NZ)
Title: Saccharifying biomass
Inventor: MEDOFF MARSHALL
IPC: D21C1/10
Filed: 2010-02-11
Abstract: Disclosed is a method comprising: providing a cellulosic or lignocellulosic feedstock, mixing the feedstock with a fluid and a saccharifying agent, and transporting the resulting mixture. Also disclosed is a composition such as a sugar concentrate, comprising about 10-70 weight percent glucose, about 2-35 weight percent xylose, and a fluid, such as a solvent; wherein the total sugar content of the composition is from about 10-90 weight percent.
Patent NZ-622180-A (NZ)
Title: Methods and compositions for regulation of transgene expression
Inventor: REBAR EDWARD J
IPC: C12N15/85
Filed: 2012-09-21
Abstract: Discloses a non-naturally occurring fusion protein comprising (i) a zinc finger protein that binds to an endogenous albumin gene and (ii) a cleavage domain, wherein the fusion protein cleaves the endogenous albumin gene, and wherein the zinc finger protein comprises 4, 5, or 6 zinc finger domains, each zinc finger domain comprising a recognition helix region, wherein the zinc finger proteins comprise the recognition helix regions shown in a single row of Table 1, Table 3, Table 5 or Table 8. Also discloses use of such a protein to treat for cleaving albumin and treating A1AT-deficiency disorders.
Patent NZ-629912-A (NZ)
Title: A winding machine and winding cage for a helically wound pipe
Inventor: DUNCAN ROY
IPC: F16L55/18
Filed: 2013-03-22
Abstract: A winding cage for winding a helically wound pipe from an elongate ribbed strip having opposed joinable edge portions is disclosed. The winding cage includes: a curved primary frame, the curved primary frame describing a primary arc of at least 120 degrees; a strip guiding assembly disposed around and supported by the curved primary frame, the strip guiding assembly arranged to guide a strip around a helical path, the strip guiding assembly defining a strip path, the strip path forming at least a portion of a helix having a longitudinal axis; and a plurality of arms spread circumferentially around and extending from the curved primary frame in a direction having a component parallel to the longitudinal axis, the arms forming part of the strip guiding assembly and arranged to support respective guide sub-assemblies.
Patent NZ-713299-A (NZ)
Title: Method for the determination of the presence of an antibiotic in a fluid
Inventor: JAGESAR DHIREDJ CHANDRE
IPC: C12Q1/00
Filed: 2014-04-30
Abstract: The present invention provides a method and test for the determination of the presence or absence of an aminoglycoside antibiotic in a sample such as milk. The method involves adding a known amount of an aminoglycoside antibiotic into the test medium before the sample is added in order to increase the sensitivity of detection for aminoglycoside antibiotics in the sample
Patent NZ-725161-A (NZ)
Title: Substituted [1,2,4] triazolo [1,5-a] pyrimidin-7-yl compounds as pde2 inhibitors
Inventor: BREITENBUCHER JAMES
IPC: C07D519/00
Filed: 2015-04-22
Abstract: The invention provides a chemical entity of Formula (I) wherein R1, R2, X, Y and Z have any of the values described herein, and compositions comprising such chemical entities; methods of making them; and their use in a wide range of methods as disclosed herein, including metabolic and reaction kinetic studies; detection and imaging techniques; radioactive treatments; modulating and treating disorders mediated by PDE2 activity; treating neurological disorders, CNS disorders, dementia, neurodegenerative diseases, and trauma-dependent losses of function; treating stroke, including cognitive and motor deficits during stroke rehabilitation; facilitating neuroprotection and neurorecovery; enhancing the efficiency of cognitive and motor training, including animal skill training protocols; and treating peripheral disorders, including hematological, cardiovascular, gastroenterological, and dermatological disorders.
Patent NZ-733938-A (NZ)
Title: Downrod assembly and ceiling fan
Inventor: TANG XINMIN
IPC: F04D29/64
Filed: 2016-04-19
Abstract: The present disclosure provides a downrod assembly and a ceiling fan. The downrod assembly includes: an electric motor, an adapter subassembly and a downrod. The adapter subassembly is connected with an electric motor shaft of the electric motor; and the downrod is connected with the adapter subassembly and is capable of rotating with respect to the electric motor by means of the adapter subassembly. For the ceiling fan provided by the present disclosure, the downrod is able to rotate with respect to the electric motor, and the downrod is folded during transportation and handling to reduce the volume of the ceiling fan, thereby reducing the packaging volume. On the one hand, it is possible to avoid loss of small parts caused by detaching and packaging individual parts of the ceiling fan. On the other hand, it is possible to avoid an inconvenient handling and a low transport efficiency of the ceiling fan caused by a large volume of the downrod and the electric motor in the assembled ceiling fan. The volume of the ceiling fan is relatively small after the downrod rotates with respect to the electric motor, such that more ceiling fans can be transported without changing the space for transportation in a transport device, thereby improving the transport efficiency, and moreover, manual handling may be convenient, thereby improving handling efficiency.
Patent NZ-773837-A (NZ)
Title: Methods and systems for diagnosing and treating health ailments
Inventor: SAMEC NICOLE
IPC: G02B6/26
Filed: 2016-03-16
Abstract: In order to diagnose, monitor, and treat health conditions and ailments, including ophthalmic as well as other conditions and ailments, a wearable augmented reality device is proposed and includes an augmented reality head-mounted ophthalmic system comprising: a frame configured to be worn on the head of a wearer wearing the head-mounted ophthalmic system; one or more light sensors attached to the frame; and an augmented reality display attached to the frame and comprising a light source, the display configured to: pass light from the world into an eye of the wearer; and output light from the light source into the eye of the wearer to form an image in the eye, wherein the wearable augmented reality device is configured to: detect an exposure amount of one or more wavelengths of light propagating towards the eye; and modify the exposure amount of the one or wavelengths of light reaching the eye based on the detected exposure amount.